Engineered dengue virus domain III proteins elicit cross-neutralizing antibody responses in mice

Authors

Julia C. Frei, Albert Einstein College of Medicine
Ariel S. Wirchnianski, Albert Einstein College of Medicine
Jennifer Govero, Washington University School of Medicine in St. Louis
Olivia Vergnolle, Albert Einstein College of Medicine
Kimberly A. Dowd, National Institutes of Health
Theodore C. Pierson, National Institutes of Health
Margaret Kielian, Albert Einstein College of Medicine
Mark E. Girvin, Albert Einstein College of Medicine
Michael S. Diamond, Washington University School of Medicine in St. Louis
Jonathan R. Lai, Albert Einstein College of Medicine

Journal

Journal of Virology

Publication Date

2018

Volume

92

Issue

18

Inclusive Pages

e01023-18

Document Type

Open Access Publication

DOI

10.1128/JVI.01023-18

Rights and Permissions

Frei, J. C., Wirchnianski, A. S., Govero, J., Vergnolle, O., Dowd, K. A., Pierson, T. C., . . . Lai, J. R. (2018). Engineered dengue virus domain III proteins elicit cross-neutralizing antibody responses in mice. Journal of Virology, 92(18) doi:10.1128/JVI.01023-18.

Recommended Citation

Frei, Julia C.; Wirchnianski, Ariel S.; Govero, Jennifer; Vergnolle, Olivia; Dowd, Kimberly A.; Pierson, Theodore C.; Kielian, Margaret; Girvin, Mark E.; Diamond, Michael S.; and Lai, Jonathan R., "Engineered dengue virus domain III proteins elicit cross-neutralizing antibody responses in mice." Journal of Virology. 92, 18. e01023-18. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/7088